Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

NIH 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2

Conditions

Breast Neoplasms 6Sarcoma, Alveolar Soft Part 2Vulvar Neoplasms 1Vulvar Diseases 1Uterine Cervical Dysplasia 1Triple Negative Breast Neoplasms 1Rectal Neoplasms 1Papillomavirus Infections 1Ovarian Neoplasms 1Lymphoma 1Endometrial Neoplasms 1Diarrhea 1Colorectal Neoplasms 1Colonic Neoplasms 1Chondrosarcoma 1Carcinoma, Non-Small-Cell Lung 1Carcinoma in Situ 1

Interventions

Ifosfamide 4Sunitinib 3Radiotherapy 3Doxorubicin 3perifosine 2cediranib 2Loperamide 2Filgrastim 2sargramostim 1romidepsin 1pembrolizumab 1pazopanib 1indolepropanol phosphate 1atropine sulfate-diphenoxylate hydrochloride drug combination 1Watchful Waiting 1Warfarin 1Vitamin B 6 1Trabectedin 1Thyroxine 1Radiotherapy, Conformal 1Pyridoxine 1Promethazine 1Prochlorperazine 1Petrolatum 1Observation 1Nivolumab 1Methotrexate 1Mass Spectrometry 1Lorazepam 1Imatinib Mesylate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Sarcoma, Alveolar Soft Part × Loperamide × Clear all
NCT01391962 2026-02-02

Sunitinib or Cediranib for Alveolar Soft Part Sarcoma

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
34 enrolled 22 charts
Sarcoma

Sarcoma, Alveolar Soft Part

NCT00401388 2018-03-07

A Trial of Perifosine in Patients With Chemo-Insensitive Sarcomas

AEterna Zentaris

Phase 2 Completed
72 enrolled
Sarcoma

Chondrosarcoma, Sarcoma, Alveolar Soft Part

Data powered by HemOnc (CC BY 4.0) Colophon âš¡